Clear Harbor Asset Management’s Tango Therapeutics TNGX Stock Holding History

Clear Harbor Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,300	Closed	-$255K	–	480
2025 Q3	$255K	Buy	30,300 +1	+0%	+$7	0.02%	372
2025 Q2	$155K	Hold	30,299	–	–	0.01%	389
2025 Q1	$41.5K	Buy	30,299 +4,804	+19%	+$11.8K	﹤0.01%	402
2024 Q4	$78.8K	Hold	25,495	–	–	0.01%	381
2024 Q3	$196K	Hold	25,495	–	–	0.02%	339
2024 Q2	$219K	Hold	25,495	–	–	0.02%	324
2024 Q1	$202K	Buy	25,495 +4,295	+20%	+$46K	0.02%	335
2023 Q4	$210K	Buy	21,200 +1,069	+5%	+$9.28K	0.02%	321
2023 Q3	$227K	Buy	20,131 +3,657	+22%	+$22.3K	0.02%	296
2023 Q2	$54.7K	Buy	+16,474	New	+$59.3K	0.01%	350

Other funds holding TNGX

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clear Harbor Asset Management's TNGX Position: Q4 2025 in Review

Clear Harbor Asset Management sold out of Tango Therapeutics (TNGX) in Q4 2025, closing a stake of 30,300 shares — an estimated $255K sold.

Clear Harbor Asset Management first reported a position in TNGX in Q2 2023 and held it in 10 quarters. The position peaked at $255K in Q3 2025. 170 funds tracked by Wall St. Rank hold TNGX as of Q4 2025.

Clear Harbor Asset Management reported no remaining Tango Therapeutics position as of Q4 2025 after selling out during the quarter.
Clear Harbor Asset Management sold 30,300 Tango Therapeutics shares in Q4 2025, an estimated $255K.
Clear Harbor Asset Management first reported a position in Tango Therapeutics in Q2 2023 and held it in 10 quarters.
Clear Harbor Asset Management's Tango Therapeutics position peaked at $255K in Q3 2025.
170 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2025.

Based on Clear Harbor Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.